Editor-in-Chief
Professor of Pediatric HematologyOncology and Stem Cell Transplantation
Pediatric HematologyOncology Stem Cell Transplantation Department
Tehran University of Medical Sciences
Iran
Editor-in-Chief
Assistant Professor
Department of Nutrition, Health and oncology
Moulay Ismail University
Morocco
Editor-in-Chief
Director-cum-Principal
Pharmacy
Amity University Madhya Pradesh, Gwalior, India
India
Editor-Member
Biologist
Material Measurement Laboratory
National Institute of Standards and Technology
United States
Editor-Member
Department of Hygiene and Public Health, Rimini, Italy
Italy
Editor-Member
Postgraduate Researcher
Department of Pharmaceutical Sciences
RTM Nagpur University, Nagpur, Maharashtra.
India
Editor-Member
Principal Investigator
Gastroenterology and Liver Diseases
Shahid Beheshti University of Medical Sciences
Iran
Editor-Member
Research Collaborator
Immunology Research Center
Iran University of Medical Sciences
Iran
Editor-Member
Postdoctoral Scientist
Cancer Immunotherapy
University of California, Irvine
United States of America
Editor-Member
Assistant Professor
Cancer Immunotherapy
Fujian Medical University
China
Editor-Member
Postdoctoral Researcher
Department of Medical Life Sciences and Technology
Technical University of Munich
Germany
The Journal of Targeted Oncology Research (JTOR) is an open-access journal dedicated to publishing cutting-edge research in oncology and targeted cancer therapies. The journal aims to promote the global exchange of knowledge and foster collaboration among researchers, clinicians, and healthcare professionals working to advance cancer diagnosis, treatment, and precision medicine.
JTOR serves as a comprehensive platform for disseminating innovative findings in cancer biology, molecular oncology, and translational research. It is committed to improving outcomes for cancer patients by highlighting advancements in targeted therapies, immunotherapies, and precision-based approaches.
The scope of JTOR encompasses all aspects of oncological research, with a particular focus on:
JTOR covers a broad spectrum of cancer types, including but not limited to breast, lung, gastrointestinal, genitourinary, hematological, and pediatric cancers. It also explores emerging areas such as cancer genomics, epigenetics, systems biology, and artificial intelligence in oncology.
By fostering interdisciplinary collaboration and providing a trusted global platform for scientific exchange, JTOR seeks to accelerate the translation of laboratory discoveries into effective clinical applications. The journal upholds a rigorous peer-review process to ensure the publication of high-quality, impactful research that drives progress in oncology and enhances patient outcomes.
With a mission to support evidence-based practice and promote innovation in cancer treatment, the Journal of Targeted Oncology Research (JTOR) aspires to be a leading international resource for oncologists, researchers, and industry professionals working toward a future where cancer is more effectively managed and ultimately, cured.
Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editorialoffice@confseries.net
Rapid Publication Service
Confseries Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Confseries follows a structured editorial and peer-review process designed to ensure academic quality, ethical integrity, and timely publication. Each manuscript progresses through clearly defined stages,as illustrated in the peer review workflow.
Manuscript Submission
Authors submit their manuscripts through the Confseries submission platform. All submissions must
comply with the journal’s scope, author instructions, and ethical standards.
Editorial Office Initial Check
Each new submission undergoes an initial assessment by the editorial office to confirm:
Manuscripts identified with major plagiarism, duplicate submission, or serious ethical issues are rejected at this stage without external review. Submissions meeting basic requirements proceed to peer review.
After passing the initial screening:
Reviewer Assessment
Reviewers critically evaluate the manuscript focusing on:
Editorial Decision
Based on reviewer feedback and editorial evaluation, one of the following decisions is issued:
Revision and Re-evaluation
For manuscripts requiring revision:
Acceptance and Publication
Manuscripts accepted for publication proceed to the production phase, which includes:
Ethical and Editorial Integrity
The Confseries peer-review workflow reflects a clear, ethical, and quality-driven editorial process, ensuring that every manuscript is evaluated rigorously before publication.
